Krembil Research Institute

Results: 1



#Item
1AVROBIO Inc. Launches to Develop Novel, Clinical-Stage Cell and Gene Therapies Targeting Immuno-Oncology and Rare Diseases Disruptive Therapies with Potential to Displace Standard of Care Treatments for Acute Myeloid Leu

AVROBIO Inc. Launches to Develop Novel, Clinical-Stage Cell and Gene Therapies Targeting Immuno-Oncology and Rare Diseases Disruptive Therapies with Potential to Displace Standard of Care Treatments for Acute Myeloid Leu

Add to Reading List

Source URL: www.ccrm.ca

Language: English - Date: 2016-02-18 12:07:01